Home
About
About Us
Leadership
Science
Pipeline
Careers
News
Contact
EN
/
中文
Home
>
News
Press Releases
LTZ Announces over $10 Million Pre-A+ Financing to Advance Development of its Immunotherapy Pipeline to Treat Cancer and Autoimmune Diseases
2023-05-31
LTZ Therapeutics Secures $17 Million Pre-Series A Financing for Immunotherapy Development to Treat Cancer & Other Complex Diseases
2022-04-07
News Articles
ENDPOINTS
Pharma vets with Genentech connection band together to launch new immunotherapy startup, though details are scant
2022-05-10
BioWorld
Former Genentech execs launch new immunotherapy biotech LTZ Therapeutics
2022-05-03
© Copyright LTZ Therapeutics All rights reserved